Dr Simran Maggo

Chua, E. W., Maggo, S., & Kennedy, M. A. (2017). Long fragment polymerase chain reaction. In L. Domingues (Ed.), PCR: Methods in molecular biology (Vol. 1620). (pp. 65-74). New York, NY: Springer. doi: 10.1007/978-1-4939-7060-5_3

Chapter in Book - Research

Maggo, S. D. S., & Ashton, J. C. (2015). Statins and the brain: Good, bad or both? In E. R. Travers (Ed.), Statins: Medical uses, mechanisms of action and clinical outcomes. (pp. 81-104). Nova Science.

Chapter in Book - Research

Kee, P. S., Maggo, S. D. S., Kennedy, M. A., & Chin, P. K. L. (2023). The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses [Brief research report]. Frontiers in Pharmacology, 14, 1080117. doi: 10.3389/fphar.2023.1080117

Journal - Research Article

Hitchman, L. M., Faatoese, A., Merriman, T. R., Miller, A. L., Liau, Y., Graham, O. E. E., Kee, P. S., Pearson, J. F., … Cameron, V. A., Kennedy, M. A., & Maggo, S. D. S. (2022). Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples. Frontiers in Genetics, 13, 1016416. doi: 10.3389/fgene.2022.1016416

Journal - Research Article

Searchfield, G. D., Poppe, T. N. E. R., Durai, M., Jensen, M., Kennedy, M. A., Maggo, S., Miller, A. L., … Russell, B. R., … Wise, K. (2020). A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity. International Journal of Neuroscience, 130(7), 671-682. doi: 10.1080/00207454.2019.1702544

Journal - Research Article

Liau, Y., Cree, S. L., Maggo, S., Miller, A. L., Pearson, J. F., Gladding, P. A., & Kennedy, M. A. (2019). A multiplex pharmacogenetics assay using the MinION nanopore sequencing device. Pharmacogenetics & Genomics, 29(9), 207-215. doi: 10.1097/fpc.0000000000000385

Journal - Research Article

Liau, Y., Maggo, S., Miller, A. L., Pearson, J. F., Kennedy, M. A., & Cree, S. L. (2019). Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications. Pharmacogenomics, 20(14), 1033-1047. doi: 10.2217/pgs-2019-0080

Journal - Research Article

Maggo, S. D. S., Sycamore, K. L. V., Miller, A. L., & Kennedy, M. A. (2019). The three ps: Psychiatry, pharmacy, and pharmacogenomics, a brief report from New Zealand. Frontiers in Psychiatry, 10, 690. doi: 10.3389/fpsyt.2019.00690

Journal - Research Article

Adehin, A., Bolaji, O. O., Maggo, S., & Kennedy, M. A. (2018). Genetic polymorphism of CYP2C9 and VKORC1 in the Nigerian population: Significance for warfarin therapy in the population. Polish Annals of Medicine, 25(2), 180-183. doi: 10.29089/2017.17.00041

Journal - Research Article

Maggo, S., & Ashton, J. C. (2018). Effect of cannabinoid receptor agonists on isolated rat atria. Journal of Cardiovascular Pharmacology, 72(4), 191-194. doi: 10.1097/fjc.0000000000000613

Journal - Research Article

Adehin, A., Bolaji, O. O., Maggo, S., & Kennedy, M. A. (2017). Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population. Drug Metabolism & Personalized Therapy, 32(1), 39-47. doi: 10.1515/dmpt-2016-0041

Journal - Research Article

Maggo, S. D. S., Chua, E. W., Chin, P., Cree, S., Pearson, J., Doogue, M., & Kennedy, M. A. (2017). A New Zealand platform to enable genetic investigation of adverse drug reactions. New Zealand Medical Journal, 130(1466), 62-69. Retrieved from http://www.nzma.org.nz/journal

Journal - Research Article

Maggo, S. D. S., Savage, R. L., & Kennedy, M. A. (2016). Impact of new genomic technologies on understanding adverse drug reactions. Clinical Pharmacokinetics, 55(4), 419-436. doi: 10.1007/s40262-015-0324-9

Journal - Research Article

Maggo, S., & Ashton, J. C. (2014). Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig. European Journal of Pharmacology, 723, 294-304. doi: 10.1016/j.ejphar.2013.11.018

Journal - Research Article

Harrison-Woolrych, M., Härmark, L., Tan, M., Maggo, S., & van Grootheest, K. (2012). Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: A case series from two national pharmacovigilance centres. European Journal of Clinical Pharmacology, 68, 1065-1072. doi: 10.1007/s00228-012-1220-y

Journal - Research Article

Harrison-Woolrych, M., Maggo, S., Tan, M., Savage, R., & Ashton, J. (2012). Cardiovascular events in patients taking varenicline: A case series from intensive postmarketing surveillance in New Zealand. Drug Safety, 35(1), 33-43. doi: 10.2165/11597690-000000000-00000

Journal - Research Article

Maggo, S., Clark, D., & Ashton, J. C. (2012). The effect of statins on performance in the Morris water maze in guinea pig. European Journal of Pharmacology, 674(2-3), 287-293. doi: 10.1016/j.ejphar.2011.11.006

Journal - Research Article

Rivers, J. R., Maggo, S. D. S., & Ashton, J. C. (2012). Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia. NeuroReport, 23(3), 134-138. doi: 10.1097/WNR.0b013e32834ee47c

Journal - Research Article

Maggo, S. D. S., Kennedy, M. A., & Clark, D. W. J. (2011). Clinical implications of pharmacogenetic variation on the effects of statins. Drug Safety, 34(1), 1-19. doi: 10.2165/11584380-000000000-00000

Journal - Research Article

Kee, P. S., Chin, P. K. L., Kennedy, M. A., & Maggo, S. D. S. (2020). Pharmacogenetics of statin-induced myotoxicity. Frontiers in Genetics, 11, 575678. doi: 10.3389/fgene.2020.575678

Journal - Research Other

Liau, Y., Chua, I., Kennedy, M. A., & Maggo, S. (2019). Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema. Clinical & Experimental Allergy, 49, 142-154. doi: 10.1111/cea.13326

Journal - Research Other

Maggo, S., Kennedy, M. A., Barczyk, Z. A., Miller, A. L., Rucklidge, J. J., Mulder, R. T., & Foulds, J. A. (2019). Common CYP2D6, CYP2C9, and CYP2C19 gene variants, health anxiety, and neuroticism are not associated with self-reported antidepressant side effects [Brief report]. Frontiers in Genetics, 10, 1199. doi: 10.3389/fgene.2019.01199

Journal - Research Other

Foulds, J. A., Maggo, S. D. S., & Kennedy, M. A. (2016). Personalised prescribing in psychiatry: Has pharmacogenomics delivered on its promise? Australian & New Zealand Journal of Psychiatry, 50(6), 509-510. doi: 10.1177/0004867416640099

Journal - Research Other

Maggo, S. (2011). Research highlights: Highlights from the latest articles in statin pharmacogenomics. Pharmacogenomics, 12(6), 773-778. doi: 10.2217/pgs.11.57

Journal - Research Other

Maggo, S., Kee, J., Hitchman, L., Chin, P., Doogue, M., Miller, A., … Kennedy, M. (2021). Assessing the pharmacogenomic landscape of adverse drug reactions in Aotearoa [Invited]. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go

Conference Contribution - Published proceedings: Abstract

Liu, W., Liau, Y., Maggo, S., Doogue, M., & Kennedy, M. (2019). Exploring combinatorial genetic contributions to a serious adverse drug reaction. Proceedings of the MapNet Meeting. (pp. 28). Retrieved from http://mapnet2019.nz/

Conference Contribution - Published proceedings: Abstract

Maggo, S., Kennedy, M., Barczyk, Z., Miller, A., Rucklidge, J., Mulder, R., & Foulds, J. (2019). Pharmacogenetic variants and psychological factors do not explain self-reported antidepressant side effects. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia & New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 66). Retrieved from https://www.asceptasm.com

Conference Contribution - Published proceedings: Abstract

Maggo, S., Liau, Y., Doogue, M., & Kennedy, M. (2018). Understanding drug reactions using genome sequencing (UDRUGS) study: A New Zealand initiative to investigate the genetics of ADRs. Basic & Clinical Pharmacology & Toxicology, 123(Suppl. 1), (pp. 3). doi: 10.1111/bcpt.13020

Conference Contribution - Published proceedings: Abstract

Cree, S., Maggo, S., Slow, S., Ton, K., de Jong, L., Anderson, T., Pearson, J., Miller, A., Walker, L., Murdoch, D., & Kennedy, M. (2017). Long read nanopore sequencing in the laboratory. Proceedings of the MapNet Conference. Retrieved from http://scienceevents.co.nz/mapnet/

Conference Contribution - Published proceedings: Abstract

Kennedy, M. A., Maggo, S. D. S., Foulds, J., Luty, S., Chua, E. W., Cree, S., Ton, K., Liau, Y., Miller, A. L., Chin, P., … Doogue, M. (2017). DNA banking and genetic analysis of adverse drug reactions in the New Zealand healthcare setting. Proceedings of the American Society of Human Genetics (ASHG) Annual Meeting. 2123. Retrieved from http://www.ashg.org/2017meeting/

Conference Contribution - Published proceedings: Abstract

Maggo, S. D. S., Young, J., Lehnert, K., George, P., & Kennedy, M. A. (2016). Understanding adverse drug reactions using genome sequencing (UDRUGS): A focus on statin induced myalgia. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 44). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/

Conference Contribution - Published proceedings: Abstract

Maggo, S., Young, J., Lehnert, K., George, P., & Kennedy, M. A. (2016). Statin induced myalgia, is there a genetic link? Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and the Molecular Pharmacology of G Protein-Coupled Receptors (ASCEPT-MPGPCR) Joint Scientific Meeting. 334. Retrieved from http://www.asceptasm.com/

Conference Contribution - Published proceedings: Abstract

Ashton, J. C., Mockett, B., & Maggo, S. D. S. (2012). Cholesterol lowering through HMG CoA reductase inhibitors (statins) impairs long term potentiation and induces anxiety in guinea pigs. Proceedings of the Australian Neuroscience Society (ANS) Annual Scientific Meeting. (pp. 78). Retrieved from http://www.ans.org.au/ans-annual-conference/

Conference Contribution - Published proceedings: Abstract

Maggo, S. D. S., Mockett, B. G., & Ashton, J. C. (2012). The effects of chronic statin administration: Assessment of hippocampal spatial memory and long term potentiation in area CA1. In B. Leitch & J. Shemmell (Eds.), Proceedings of the 30th International Australasian Winter Conference on Brain Research. 30, (pp. 75). AWCBR. Retrieved from http://psy.otago.ac.nz/awcbr/Abstracts/Abstracts2012.html

Conference Contribution - Published proceedings: Abstract

Maggo, S. D. S., Mockett, B. G., & Ashton, J. C. (2012). The effects of chronic statin administration: Assessment of hippocampal spatial memory and long term potentiation in area CA1. Proceedings of the Medical Sciences Congress (MedSci). (pp. 24-25). Retrieved from http://www.medscinz.co.nz/QRW2012%20MedSci%20Abstracts.pdf

Conference Contribution - Published proceedings: Abstract

Maggo, S. D., Mockett, B. G., & Ashton, J. C. (2011). Cholesterol lowering through HMG CoA reductase inhibitors (statins) impairs long term potentiation and induces anxiety in guinea pigs. Proceedings of the Society for Neuroscience 41st Annual Meeting. SfN. Retrieved from http://www.sfn.org/am2011/index.aspx?pagename=abstracts_main

Conference Contribution - Published proceedings: Abstract

Maggo, S., Mockett, B. G., & Ashton, J. C. (2011). Cholesterol lowering through HMG CoA reductase inhibitors (statins) impairs long term potentiation and induces anxiety in guinea pigs. In B. Leitch (Ed.), Proceedings of the 29th International Australasian Winter Conference on Brain Research. 29, 4.8. AWCBR. Retrieved from http://psy.otago.ac.nz/awcbr/abstracts/abstracts2011.html

Conference Contribution - Published proceedings: Abstract

Maggo, S., Clark, D. W. J., & Ashton, J. (2010). Statin induced anxiety: What happens when you make guinea pigs swim. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting and the 6th Annual Carney Pharmacogenomics Symposium. ASCEPT. Retrieved from http://www.ascept.org.nz/

Conference Contribution - Published proceedings: Abstract

Maggo, S., Savage, R., Ashton, J. A., & Clark, D. W. G. (2008). Retrospective analysis of psychiatric effects reported for HMG-COA reductase inhibitors (STATINS) at the NZPHVC. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting. ASCEPT. Retrieved from http://phal.otago.ac.nz/ascept_docos/programme%202008.pdf

Conference Contribution - Published proceedings: Abstract

Hitchman, L. M., Faatoese, A., Merriman, T. R., Miller, A. L., Liau, Y., Graham, O. E. E., Kee, P. S., Pearson, J. F., … Cameron, V. A., Kennedy, M. A., & Maggo, S. D. S. (2022, August-September). Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Poster Presentation (not in published proceedings)

Kee, P. S., Maggo, S., Kennedy, M. A., Barclay, M. L., Miller, A., Lehnert, K., … Faull, R. L. M., … Chin, P. K. L. (2022, August-September). Omeprazole treatment failure in gastro-oesophageal reflux disease and genetic variation at the CYP2C locus. Verbal presentation at the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Liau, Y., Maggo, S., Lehnert, K., Doogue, M. P., Scull, A., Miller, A. L., Pearson, J. F., & Kennedy, M. A. (2022, August-September). Genomic analysis of angiotensin converting enzyme inhibitor-induced angioedema. Verbal presentation at the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Kennedy, M. A., Cree, S. L., Miller, A. L., Pearson, J., Maggo, S., Liau, Y., Ton, K., de Jong, L., & Walker, L. C. (2017, September). The MinION nanopore sequencer: Toy or tool? Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Liau, Y., Cree, S. M., Maggo, S., Miller, A. L., Pearson, J., & Kennedy, M. A. (2017, September). A nanopore sequencing-based multiplex assay for pharmacogenetics of clopidogrel and warfarin. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Cree, S. L., Miller, A. L., Chua, E. W., Maggo, S., & Kennedy, M. A. (2015, August). Long-read nanopore Sequencing for the detection of genetic polymorphisms in the CYP2D6 gene. Verbal presentation at the 7th Annual New Zealand Next Generation Sequencing (NGS) Conference, Palmerston North, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Maggo, S. D. S., Foulds, J., Luty, S. E., Miller, A. L., Kennedy, H., Doogue, M., & Kennedy, M. A. (2015, September). Understanding adverse drug reactions using genome sequencing (UDRUGS): Recent cases on SSRIs and SNRIs. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Maggo, S. (2014, November). Gentamicin ototoxicity, pharmacogenetic link? Verbal presentation at the 10th Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Lees, G., Dixon, C., Maggo, S., Clark, D., Tyndall, J., & Strandell, J. (2009, September). Modulation of ion channels by the antiviral drug efavirenz. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting, Dunedin, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Maggo, S. D. S., Ashton, J. C., Lees, G., & Clark, D. W. J. (2009, September). Lipid lowering drugs and psychiatric ADRS: An animal behavioural assessment. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting, Dunedin, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Maggo, S., Strandell, J., & Clark, D. W. J. (2007, August). Are psychiatric effects reported for HMG-COA reductase inhibitors (statins) likely to be true adverse drug reactions? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (NZ) Annual Scientific Meeting, Auckland, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs